Inventor · disambiguated record
Brian Lee Venables
Also filed as: VENABLES BRIAN · VENABLES BRIAN LEE
16 granted patents·9 pending applications·271 citations·filing 2001–2024
93Inventor score
Files withBRISTOL MYERS SQUIBB CO14VIIV HEALTHCARE UK NO 5 LTD5VIIV HEALTHCARE UK NO 4 LTD4REGUEIRO-REN ALICIA1SIN NY1
Top patents by PatentIndex Score
25 records- 0197US7323447B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 29, 2008·50 cites·26 claims
- 0296US7041698B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 9, 2006·135 cites·19 claims
- 0395US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0493US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 0592US8846647B2C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activityREGUEIRO-REN ALICIA·Filed 2012·Granted Sep 30, 2014·19 cites·16 claims
- 0690US7772180B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 10, 2010·17 cites·20 claims
- 0785US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 0884US6489338B2Imidazopyridine and imidazopyrimidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 3, 2002·25 cites·7 claims
- 0983US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 1081US8163921B2Hepatitis C virus inhibitorsSIN NY·Filed 2009·Granted Apr 24, 2012·9 cites·16 claims
- 1179US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 1278US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1377US2023295220A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2022·Application pending·0 cites
- 1476US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 1573US6774134B2Heterocyclic substituted 2-methyl-benzimidazole antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 10, 2004·5 cites·7 claims
- 1671US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 1769US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 1865US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 1959US2014343000A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2052US2009285774A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2150US2016151387A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2249US6844342B2Heterocyclic substituted 2-methyl-benzimidazole antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 18, 2005·0 cites·8 claims
- 2345US2019135857A1Triterpenoid inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Application pending·0 cites
- 2445US2014221361A1C-19 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2544US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Brian Lee Venables files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →